Statistics

Total Visits

Views
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation14

Select a period of time:

Number of views in the range

Views
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation10

Views

Views
November 20230
December 20232
January 20241
February 20241
March 20241
April 20243
May 20242
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
 

Top cities views

Views
Ashburn3
Chicago2
Boardman1